Novo Nordisk A/S reports share repurchases of 1,150,000 B shares from April 20-24, 2026, under its DKK 3.8 billion program initiated February 4, 2026, bringing total repurchased to 13,407,992 B shares.
Key takeaways
Repurchased 230,000 B shares each day from April 20-24, 2026, at average prices of DKK 249.19-255.95.
Cumulative repurchases under the program: 13,407,992 B shares for DKK 3,438,931,195 at average price DKK 256.48.
Program limit: up to DKK 3.8 billion from February 4 to May 4, 2026; overall up to DKK 15 billion over 12 months.
Total treasury B shares: 30,797,791, or 0.7% of share capital (total A and B shares: 4,465,000,000).